Rhumbline Advisers Albireo Pharma, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $20,801 - $27,465	1,155 Added 5.42%	22,452 $485,000
Q3 2022 Nov 10, 2022	BUY	$16.32 - $26.37 $23,239 - $37,550	1,424 Added 7.17%	21,297 $412,000
Q2 2022 Aug 11, 2022	BUY	$18.54 - $37.29 $35,281 - $70,962	1,903 Added 10.59%	19,873 $395,000
Q1 2022 May 12, 2022	BUY	$23.94 - $33.74 $5,171 - $7,287	216 Added 1.22%	17,970 $536,000
Q4 2021 Feb 10, 2022	SELL	$21.19 - $31.29 $6,484 - $9,574	-306 Reduced 1.69%	17,754 $413,000
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $16,443 - $21,623	601 Added 3.44%	18,060 $563,000
Q2 2021 Aug 05, 2021	SELL	$28.9 - $36.87 $37,772 - $48,189	-1,307 Reduced 6.96%	17,459 $614,000
Q1 2021 May 06, 2021	SELL	$32.03 - $42.85 $31,069 - $41,564	-970 Reduced 4.91%	18,766 $662,000
Q4 2020 Feb 10, 2021	BUY	$31.56 - $42.16 $118,570 - $158,395	3,757 Added 23.51%	19,736 $740,000
Q3 2020 Nov 12, 2020	SELL	$23.19 - $41.61 $29,288 - $52,553	-1,263 Reduced 7.33%	15,979 $533,000
Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $51,054 - $103,074	3,445 Added 24.97%	17,242 $457,000
Q1 2020 May 06, 2020	BUY	$11.67 - $27.23 $6,476 - $15,112	555 Added 4.19%	13,797 $226,000
Q4 2019 Feb 05, 2020	BUY	$16.92 - $28.96 $1,556 - $2,664	92 Added 0.7%	13,242 $337,000
Q3 2019 Oct 23, 2019	BUY	$20.0 - $31.88 $2,000 - $3,188	100 Added 0.77%	13,150 $263,000
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $4,416 - $5,451	144 Added 1.12%	13,050 $421,000
Q1 2019 May 01, 2019	SELL	$22.22 - $32.21 $3,333 - $4,831	-150 Reduced 1.15%	12,906 $416,000
Q4 2018 Jan 31, 2019	BUY	$20.9 - $32.57 $78,228 - $121,909	3,743 Added 40.19%	13,056 $320,000
Q3 2018 Nov 07, 2018	SELL	$29.29 - $36.87 $3,661 - $4,608	-125 Reduced 1.32%	9,313 $307,000
Q2 2018 Aug 06, 2018	BUY	$28.9 - $37.31 $272,758 - $352,131	9,438 New	9,438 $335,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account